These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19719543)

  • 21. Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study.
    Yu S; Zhou J; Luo G; Xiao Z; Ettrup A; Jansson G; Florea I; Ranc K; Pozo-Rosich P
    BMC Neurol; 2023 Dec; 23(1):441. PubMed ID: 38102535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topiramate Monotherapy for Civilian Posttraumatic Stress Disorder: A Controlled Pilot Study.
    Monga V; Petty F; Padala K; Padala PR
    Prim Care Companion CNS Disord; 2023 Oct; 25(5):. PubMed ID: 37857291
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
    Ashina M; Tepper SJ; Gendolla A; Sperling B; Ettrup A; Josiassen MK; Starling AJ
    J Headache Pain; 2023 Nov; 24(1):155. PubMed ID: 37985968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photophobia Contributes to Migraine-Associated Disability and Reduced Work Productivity: Results From the American Registry for Migraine Research (ARMR).
    Leibovit-Reiben Z; Dumkrieger G; Dodick DW; Digre K; Chong CD; Trivedi M; Schwedt TJ
    J Neuroophthalmol; 2024 Jun; 44(2):259-266. PubMed ID: 37581595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competing treatments for migraine: a headache for decision-makers.
    Mistry H; Naghdi S; Underwood M; Duncan C; Madan J; Matharu M
    J Headache Pain; 2023 Dec; 24(1):162. PubMed ID: 38053051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
    Starling AJ; Tepper SJ; Marmura MJ; Shamim EA; Robbins MS; Hindiyeh N; Charles AC; Goadsby PJ; Lipton RB; Silberstein SD; Gelfand AA; Chiacchierini RP; Dodick DW
    Cephalalgia; 2018 May; 38(6):1038-1048. PubMed ID: 29504483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight variations in patients receiving topiramate migraine prophylaxis in a tertiary care setting.
    Krymchantowski A; Tavares C
    MedGenMed; 2004 Jul; 6(3):48. PubMed ID: 15520672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting.
    Nelles G; Schmitt L; Humbert T; Becker V; Sandow P; Bornhoevd K; Fritzsche D; Schäuble B;
    J Headache Pain; 2010 Feb; 11(1):33-44. PubMed ID: 19894100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial.
    Liu L; Chen Q; Zhao L; Lyu T; Nie L; Miao Q; Liu Y; Zheng L; Fu F; Luo Y; Zeng C; Zhang C; Peng P; Zhang Y; Li B
    Cephalalgia; 2024 Jun; 44(6):3331024241261080. PubMed ID: 38860524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Most bothersome symptom in migraine and probable migraine: A population-based study.
    Kim SJ; Lee HJ; Lee SH; Cho S; Kim KM; Chu MK
    PLoS One; 2023; 18(11):e0289729. PubMed ID: 38019845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine.
    Speck RM; Shalhoub H; Wyrwich KW; Yu R; Ayer DW; Ford J; Bush EN; Lipton RB
    Headache; 2019 May; 59(5):756-774. PubMed ID: 30861580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.
    Sharpless LK; Kesselheim AS; Orr SL; Darrow J
    Neurology; 2023 Sep; 101(10):e989-e1000. PubMed ID: 37438124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trials.
    Matsumori Y; Ishida M; Iba K; Kim BK; Ning X; Nakai M; Koga N
    Headache; 2023 Oct; 63(9):1304-1313. PubMed ID: 37602905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Melatonin on Reducing the Frequency and Severity of Migraine Attacks: A Double-Blind, Randomized Clinical Trial.
    Mehramiri A; Shalilahmadi D; Mohamadianinejad SE; Kouti L; Hosseinpour Y
    Iran J Med Sci; 2024 May; 49(5):313-321. PubMed ID: 38751874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of paranasal air suction on acute migraine using portable air sucker - a randomized, double blind study.
    Bandara SMR; Samita S; Kiridana AM; Herath HMMTB
    BMC Neurol; 2021 Apr; 21(1):176. PubMed ID: 33892652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
    Lipton RB; Halker Singh RB; Mechtler L; McVige J; Ma J; Yu SY; Stokes J; Dabruzzo B; Gandhi P; Ashina M
    Cephalalgia; 2023 Aug; 51(8):3331024231190296. PubMed ID: 37638400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic features of chronic migraine.
    Yalın OÖ; Uluduz D; Özge A; Sungur MA; Selekler M; Siva A
    J Headache Pain; 2016; 17():26. PubMed ID: 26975363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
    Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate: the evidence for its therapeutic value in the prevention of migraine.
    Nadin C
    Core Evid; 2005; 1(2):103-24. PubMed ID: 22500148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program.
    Bhola R; Kinsella E; Giffin N; Lipscombe S; Ahmed F; Weatherall M; Goadsby PJ
    J Headache Pain; 2015; 16():535. PubMed ID: 26055242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.